Nan Chen, MD

Her practice primarily focuses on treating patients with all forms of breast cancer, with particular expertise in high-risk breast cancers, including metastatic hormone receptor-positive and triple-negative breast cancer. Dr. Chen offers both standard-of-care treatments, such as chemotherapy, targeted therapy and endocrine therapy, and novel therapies through clinical trials to create individualized treatment plans for her patients.

Dr. Chen’s research interests include identifying innovative treatments for both early and advanced breast cancer, as well as discovering new biomarkers to predict response to therapies. She is very active in clinical research, managing several trials evaluating advanced care for breast cancer.

Working closely with laboratory-based researchers at the University of Chicago, Dr. Chen is developing tools that investigate mechanisms of treatment response or resistance. She has been awarded grants to fund her research and has published numerous peer-reviewed papers on breast cancer.